posted on 2025-02-11, 10:45authored byBenson Oloya, Jane Namukobe, Mandy Krüger, Willy Ssengooba, Eric Sperlich, George Kwesiga, Kevin Komakech, Matthias Heydenreich, Robert Byamukama, Bernd Schmidt
trans-Fagaramide (1) and
adubangoamide
(2) are natural products with a cinnamic acid amide skeleton
that have recently been isolated from Zanthoxylum leprieurii, a medicinal plant used locally in Uganda for the treatment of tuberculosis.
Insufficient quantities of material from the natural source originally
prevented the antimycobacterial evaluation of the new natural product 2. Herein, a synthesis of 2 is reported, and
its antimycobacterial activity was determined using the synthetic
material. Adubangoamide (2) is three times more active
against the drug-susceptible M. tuberculosis strain
H37Rv than trans-fagaramide (1), with an MIC value of 10.0 μM. In addition, we synthesized
eight non-natural analogues of trans-fagaramide (1, MIC = 32.0 μM against H37Rv strain), in
which benzylamide groups mimic the isobutylamide part of the trans-fagaramide structure. Five out of eight synthetic
analogues are more active than the parent natural product: 11b (MIC = 6.0 μM), 11d (21.0 μM), 11e (6.1 μM), 11g (17.0 μM), and 11h (4.5 μM).